Harrow Health/HROW

$10.95

1.15%
-
1D1W1MYTD1YMAX

About Harrow Health

Harrow, Inc., formerly Harrow Health, Inc., is a eyecare pharmaceutical company. The Company is engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the United States market. It provides comprehensive portfolio of prescription and non-prescription pharmaceutical products. The Company offers pharmaceutical products for ophthalmic surgeries in the United States, as well as medications prescribed to treat patients managing chronic and acute eye conditions, such as dry eye disease, glaucoma, allergies, infections, and other ophthalmic inflammatory conditions. It serves over 10,000 doctors, hospitals, and ambulatory service centers (ASCs) and regularly ship to over 1,500 institutional accounts each month.

Ticker

HROW

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Mark Baum

Employees

217

Headquarters

Nashville, United States

Harrow Health Metrics

BasicAdvanced
$384.54M
Market cap
-
P/E ratio
-$0.45
EPS
0.46
Beta
-
Dividend rate

What the Analysts think about Harrow Health

Analyst Ratings

Majority rating from 3 analysts.
Buy

Price Targets

Average projection from 3 analysts.
156.89% upside
High $34.40
Low $20.00
$10.95
Current price
$28.13
Average price target

Harrow Health Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-12.57% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$34.2M
2.4%
Net income
$-4.3M
2.38%
Profit margin
-12.57%
-0%

Harrow Health Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 467.93%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
$0.04
-$0.22
-$0.14
-$0.13
-
Expected
-$0.12
-$0.05
-$0.04
$0.04
-$0.04
Surprise
-134.29%
312.5%
250%
-467.93%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Harrow Health stock

Buy or sell Harrow Health stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing